News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA Staff Says Novartis AG and Astellas Pharma Inc. May Need Wider Eczema Caution for Kids; New Reported Cases of Cancer and Infection


3/18/2010 8:28:06 AM

Reuters -- Novartis AG (NOVN.VX) (NVS.N) and Astellas Pharma (4503.T) eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday.

Read at Reuters


comments powered by Disqus
Reuters
   
Eczema

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES